142 related articles for article (PubMed ID: 10648633)
1. 7- and 10-substituted camptothecins: dependence of topoisomerase I-DNA cleavable complex formation and stability on the 7- and 10-substituents.
Vladu B; Woynarowski JM; Manikumar G; Wani MC; Wall ME; Von Hoff DD; Wadkins RM
Mol Pharmacol; 2000 Feb; 57(2):243-51. PubMed ID: 10648633
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic camptothecin analogs that form extremely stable cleavable complexes with DNA and topoisomerase I.
Wadkins RM; Bearss D; Manikumar G; Wani MC; Wall ME; Von Hoff DD
Cancer Res; 2004 Sep; 64(18):6679-83. PubMed ID: 15374984
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin analogs with enhanced activity against human breast cancer cells. I. Correlation of potency with lipophilicity and persistence in the cleavage complex.
Adams DJ; da Silva MW; Flowers JL; Kohlhagen G; Pommier Y; Colvin OM; Manikumar G; Wani MC
Cancer Chemother Pharmacol; 2006 Jan; 57(2):135-44. PubMed ID: 16151810
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxic activity of new 9-substituted camptothecins.
Dallavalle S; Rocchetta DG; Musso L; Merlini L; Morini G; Penco S; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 May; 18(9):2781-7. PubMed ID: 18434153
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic activity of substituted 7-aryliminomethyl derivatives of camptothecin.
Dallavalle S; Merlini L; Morini G; Musso L; Penco S; Beretta GL; Tinelli S; Zunino F
Eur J Med Chem; 2004 Jun; 39(6):507-13. PubMed ID: 15183909
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I-DNA complex stability induced by camptothecins and its role in drug activity.
Wadkins RM; Bearss D; Manikumar G; Wani MC; Wall ME; Von Hoff DD
Curr Med Chem Anticancer Agents; 2004 Jul; 4(4):327-34. PubMed ID: 15281905
[TBL] [Abstract][Full Text] [Related]
7. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.
Tsao YP; Russo A; Nyamuswa G; Silber R; Liu LF
Cancer Res; 1993 Dec; 53(24):5908-14. PubMed ID: 8261402
[TBL] [Abstract][Full Text] [Related]
8. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
Holden JA; Wall ME; Wani MC; Manikumar G
Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
[TBL] [Abstract][Full Text] [Related]
9. Novel 7-alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified mammalian topoisomerase I and in human colon carcinoma SW620 cells.
Valenti M; Nieves-Neira W; Kohlhagen G; Kohn KW; Wall ME; Wani MC; Pommier Y
Mol Pharmacol; 1997 Jul; 52(1):82-7. PubMed ID: 9224816
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang YH; Liu LF; Wall ME; Wani MC; Nicholas AW; Manikumar G; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Aug; 49(16):4385-9. PubMed ID: 2545341
[TBL] [Abstract][Full Text] [Related]
11. SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin.
Horie K; Tomida A; Sugimoto Y; Yasugi T; Yoshikawa H; Taketani Y; Tsuruo T
Oncogene; 2002 Nov; 21(52):7913-22. PubMed ID: 12439742
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of IDN5174, a new synthetic camptothecin with the open lactone ring.
Beretta GL; Petrangolini G; De Cesare M; Pratesi G; Perego P; Tinelli S; Tortoreto M; Zucchetti M; Frapolli R; Bello E; Manzotti C; Fontana G; Bombardelli E; Battaglia A; Samorì C; Zunino F
Cancer Res; 2006 Nov; 66(22):10976-82. PubMed ID: 17108136
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 10,11-methylenedioxy-14-azacamptothecin.
Elban MA; Sun W; Eisenhauer BM; Gao R; Hecht SM
Org Lett; 2006 Aug; 8(16):3513-6. PubMed ID: 16869648
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis of camptothecin glycosides by phase transfer-catalysis and its inhibitory activity against topo I].
Li QY; Zhang Y; Yao LP; Fu YJ; Zu YG; Chen XQ; Zheng CY
Yao Xue Xue Bao; 2005 Dec; 40(12):1116-21. PubMed ID: 16496676
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, topoisomerase I inhibitory activity and in vitro cytotoxicity of camptothecin derivatives bearing five-membered heterocycle containing 10-substituents.
Zhao R; Guan LL; Oreski B; Lown JW
Anticancer Drug Des; 1998 Mar; 13(2):145-57. PubMed ID: 9524556
[TBL] [Abstract][Full Text] [Related]
16. BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo.
Demarquay D; Huchet M; Coulomb H; Lesueur-Ginot L; Lavergne O; Camara J; Kasprzyk PG; Prévost G; Bigg DC
Cancer Res; 2004 Jul; 64(14):4942-9. PubMed ID: 15256467
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic activity of polyamine analogues of camptothecin.
Dallavalle S; Giannini G; Alloatti D; Casati A; Marastoni E; Musso L; Merlini L; Morini G; Penco S; Pisano C; Tinelli S; De Cesare M; Beretta GL; Zunino F
J Med Chem; 2006 Aug; 49(17):5177-86. PubMed ID: 16913706
[TBL] [Abstract][Full Text] [Related]
18. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
Jung LL; Zamboni WC
Drug Resist Updat; 2001 Aug; 4(4):273-88. PubMed ID: 11998845
[TBL] [Abstract][Full Text] [Related]
19. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
20. Camptothecin: current perspectives.
Thomas CJ; Rahier NJ; Hecht SM
Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
